Reduced-fluence photodynamic therapy and anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy in an Indian population

AIMS: The aim was to study the efficacy of combined therapy with reduced-fluence photodynamic therapy (RFPDT) and intravitreal bevacizumab/ranibizumab from the Indian subcontinent. SETTINGS AND DESIGN: This was a single-center, retrospective interventional study. METHODS: Thirty-five eyes of 34 pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Sen, Parveen, Bhende, Muna, Sachidanandam, Ramya, Bansal, Nishat, Sharma, Tarun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322706/
https://www.ncbi.nlm.nih.gov/pubmed/28112132
http://dx.doi.org/10.4103/0301-4738.198856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322706/
https://www.ncbi.nlm.nih.gov/pubmed/28112132
http://dx.doi.org/10.4103/0301-4738.198856

Ejemplares similares